MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Macrogenics (MGNX) Misses Q1 EPS by 29c, Revenues Miss
April 29, 2021 4:59 PM EDTMacrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.90), $0.29 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $16.88 million versus the consensus estimate of $27.95 million.
With the recent launch and commercialization of MARGENZA, we are delivering on our vision to provide potentially... More
